跳至主要内容
临床试验/NCT04863508
NCT04863508Unknown不适用

Application of the HeartGuide Blood Pressure Watch Monitor to Identify Masked Uncontrolled Hypertension in Hypertensive Patients With Different Cardiovascular Risks In Taiwan.

National Taiwan University Hospital Hsin-Chu Branch1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2020年11月26日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
90
试验地点
1
主要终点
Occurrence of masked uncontrolled hypertension

研究概览

简要总结

Uncontrolled out-of-office blood pressure (BP), measured by either home BP monitoring (HBPM) or ambulatory BP monitoring, has been shown to predict higher cardiovascular risk. However, HBPM could not identify daytime BP surge, which leads to underestimation of future risk among treated hypertensive individuals.

HeartGuide provides validated out-of-office BP measurements, along with activity/sleep recordings. The present study is designed to examine whether BP monitoring with the HeartGuide could identify masked uncontrolled hypertension in controlled hypertensive patients based on office BP. We will enroll hypertensive patients with controlled office BP according to their cardiovascular risk profile. We will also examine prevalence of post-prandial BP changes and BP variability using HeartGuide.

详细描述

Recent hypertension guidelines stressed the importance of out-of-office BP monitoring. Ambulatory BP (ABPM) and home BP monitoring (HBPM) both predict future cardiovascular events better than office BP. Masked hypertension is an important issue. As revealed by recent studies, daytime BP surge can result in greater target organ damage for high-risk hypertensive individuals.

Previous trials such as TASMINH2 and TASMINH-SR study showed positive effects of HBPM on BP control in hypertensive patients. However, several issues preclude perfect applications of HBPM. For example, HBPM could not provide BP recordings during activity or at night-time. In addition, the currently recommended time schedule for HBPM may be insufficient for detecting daytime surge especially among high-risk individuals. Wearable BP devices seem to fill in this gap as a novel approach of out-of-office monitoring.

HeartGuide, the new watch BP monitor, was recently validated to provide accurate BP measurements. It could provide incremental knowledge with potentially larger numbers of recordings. The primary objective of this study is to unveil uncontrolled masked hypertension with HeartGuide, particularly for those undetected with current office BP and HBPM. A second objective is to assess diurnal BP trends and BP variability.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
30 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Willing to sign informed consent form
  • Currently taking anti-hypertensive therapy for more than 3 months
  • Drugs are unchanged during the study period
  • Office BP below 140/90 mmHg at least one visit

排除标准

  • Diagnosed with terminal illness
  • End-stage renal disease requiring lifelong dialysis treatment
  • Patients with impaired performance status (ECOG >= 2)
  • Women undergoing or expecting pregnancy during the study period
  • Resistant hypertension (taking more than 4 kinds of anti-hypertensive drugs)
  • Known atrial or ventricular arrhythmia
  • Wrist circumference out-of range between 13.5 to 21.5 cm

结局指标

主要结局

Occurrence of masked uncontrolled hypertension

时间窗: during 3-month follow-up period

measured BP\>=135/85 mmHg by wearable BP devices or average BP\>=130/80 mmHg by ambulatory BP monitor

次要结局

未报告次要终点

研究者

发起方
National Taiwan University Hospital Hsin-Chu Branch
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验